Literature DB >> 9106605

Successful treatment of sclerosing cervicitis and fibrosing mediastinitis with tamoxifen.

B A Savelli1, M Parshley, M L Morganroth.   

Abstract

Fibrosing mediastinitis and sclerosing cervicitis are fibrosclerotic disorders akin to retroperitoneal fibrosis, with presenting symptoms related to local pain or viscus obstruction or both. No definitive treatment is known. This is the first report of these disorders dramatically responding to tamoxifen citrate and prednisone.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9106605     DOI： 10.1378/chest.111.4.1137

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


  13 in total

1.  Successful treatment of sclerosing mediastinitis with a high serum IgG4 level.

Authors:  Masaaki Inoue; Naohiro Nose; Hitoshi Nishikawa; Masaaki Takahashi; Yoh Zen; Makoto Kawaguchi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-10

2.  Fibrosing mediastinitis: an unusual cause of pulmonary symptoms.

Authors:  Meredith A Schade; Neena M Mirani
Journal:  J Gen Intern Med       Date:  2013-06-27       Impact factor: 5.128

3.  Targeting B lymphocytes in progressive fibrosing mediastinitis.

Authors:  Blair D Westerly; Geoffrey B Johnson; Fabien Maldonado; James P Utz; Ulrich Specks; Tobias Peikert
Journal:  Am J Respir Crit Care Med       Date:  2014-11-01       Impact factor: 21.405

4.  Fibrosing mediastinitis as a cause of right claudication.

Authors:  Antonio Tancredi; Antonello Cuttitta; Carlo Del Naja; Roberto Scaramuzzi
Journal:  Updates Surg       Date:  2011-05-12

5.  Evaluation of the safety and tolerability of tamoxifen for ischemia-incited renal injury in mice.

Authors:  Yuxi Wang; Zhi Zhao; Weiqi Yang; Lin Li; Fengming Zhu; Guangchang Pei; Juan Yang; Han Zhu; Huzi Xu; Meng Wang; Qian Yang; Zhizhi Hu; Pengge Wang; Gang Xu; Rui Zeng; Ying Yao
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

6.  Effect of tamoxifen on fibrosis, collagen content and transforming growth factor-β1, -β2 and -β3 expression in common bile duct anastomosis of pigs.

Authors:  Orlando Hiroshi Kiono Siqueira; Karen Jesus Oliveira; Angela Cristina Gouvêa Carvalho; Antonio Claudio Lucas da Nóbrega; Renata Frauches Medeiros; Bruno Felix-Patrício; Fábio Otero Áscoli; Beni Olej
Journal:  Int J Exp Pathol       Date:  2017-12-04       Impact factor: 1.925

7.  Antifibrotic effect of tamoxifen in a model of progressive renal disease.

Authors:  Humberto Dellê; José Roberto C Rocha; Rita C Cavaglieri; José Mauro Vieira; Denise M A C Malheiros; Irene L Noronha
Journal:  J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 10.121

Review 8.  [Treatment of chronic mediastinitis].

Authors:  R Scheubel
Journal:  Chirurg       Date:  2016-06       Impact factor: 0.955

9.  Tamoxifen decreases the myofibroblast count in the healing bile duct tissue of pigs.

Authors:  Orlando Hiroshi Kiono Siqueira; Benedito Herani Filho; Rafael Erthal de Paula; Fábio Otero Ascoli; Antonio Cláudio Lucas da Nóbrega; Angela Cristina Gouvêa Carvalho; Andréa Rodrigues Cordovil Pires; Nicolle Cavalcante Gaglionone; Karin Soares Gonçalves Cunha; José Mauro Granjeiro
Journal:  Clinics (Sao Paulo)       Date:  2013-01       Impact factor: 2.365

Review 10.  Post-tuberculous fibrosing mediastinitis: a review of the literature.

Authors:  Zhe Wu; Hannah Jarvis; Luke S Howard; Corrina Wright; Onn Min Kon
Journal:  BMJ Open Respir Res       Date:  2017-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.